Literature DB >> 2462184

Calcitonin gene-related peptide in visceral afferent nerve fibres: quantification by radioimmunoassay and determination of axonal transport rates.

A Varro1, T Green, S Holmes, G J Dockray.   

Abstract

An antibody specific for the C-terminus of rat alpha calcitonin gene-related peptide has been used in radioimmunoassay to measure concentrations of immunoreactive peptide in the upper gastrointestinal tract of capsaicin-treated and coeliac ganglionectomized rats, and to measure axonal transport velocities in the vagus and splanchnic nerves. In adult rats that had been treated soon after birth with capsaicin, immunoreactive calcitonin gene-related peptide in the stomach and duodenum was undetectable (less than 0.1 pmol/g) compared with 4-10 pmol/g in control rats. Removal of the coeliac ganglion also reduced concentrations of immunoreactive calcitonin gene-related peptide by 5-fold, but Leu-enkephalin and Met-enkephalin Arg6Gly7Leu8-immunoreactivities (which are thought to occur in intrinsic gut neurons) were unchanged by coeliac ganglionectomy. Concentrations of calcitonin gene-related peptide immunoreactivity in coeliac ganglia were depressed by 90% in capsaicin-treated rats but concentrations of opioid peptide immunoreactivity were similar to control. The results suggest calcitonin gene-related peptide-immunoreactivity in the upper gastrointestinal tract in the rat is predominantly of extrinsic afferent origin. Chromatographic separation on Sephadex G50, or high-performance liquid chromatography revealed that the major immunoreactive form in stomach extracts corresponded to intact calcitonin gene-related peptide, although there was evidence of smaller, less hydrophobic C-terminal fragments. Direct evidence of transport of calcitonin gene-related peptide toward the gut was obtained by ligation of the cervical vagus and greater splanchnic nerves. There was accumulation on the central side of ligatures, which suggested axonal transport velocities in the vagus of about 1.5 mm/h and 0.7 mm/h in splanchnic nerves.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462184     DOI: 10.1016/0306-4522(88)90109-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Relation between cholecystokinin and antral innervation in the control of gastric emptying in the rat.

Authors:  A Higham; C Vaillant; B Yegen; D G Thompson; G J Dockray
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Immunohistochemical distribution of calcitonin gene-related peptide in nerve fibres of the anterior buccal gland of the rat.

Authors:  J Törnwall; Y T Konttinen; H Uusitalo
Journal:  Histochem J       Date:  1996-01

3.  Differential control of somatostatin messenger RNA in rat gastric corpus and antrum. Role of acid, food, and capsaicin-sensitive afferent neurons.

Authors:  A K Sandvik; R Dimaline; E R Forster; D Evans; G J Dockray
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

4.  Ablation of capsaicin sensitive afferent nerves impairs defence but not rapid repair of rat gastric mucosa.

Authors:  M A Pabst; E Schöninkle; P Holzer
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

5.  Effect of vagotomy on expression of neuropeptides and histamine in rat oxyntic mucosa.

Authors:  N Bäck; M Ahonen; O Häppölä; E Kivilaakso; T Kiviluoto
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

6.  Axoplasmic transport of calcitonin gene-related peptide in rat peripheral nerve as a function of age.

Authors:  H L Fernandez; C A Hodges-Savola
Journal:  Neurochem Res       Date:  1994-11       Impact factor: 3.996

7.  Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction.

Authors:  Chun-Hua Hang; Ji-Xin Shi; Jie-Shou Li; Wei Wu; Wei-Qin Li; Hong-Xia Yin
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.